About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Gatm
glycine amidinotransferase (L-arginine:glycine amidinotransferase)
MGI:1914342
56 phenotypes from 4 alleles in 5 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Gatmem1Btlr/Gatmem1Btlr
C57BL/6J-Gatmem1Btlr
abnormal enterocyte proliferation J:252049
decreased colon length J:252049
decreased creatine level J:252049
normal immune system phenotype J:252049
increased enterocyte apoptosis J:252049
increased physiological sensitivity to xenobiotic J:252049
increased susceptibility to induced colitis J:252049
Gatmem1Btlr/Gatmm1Btlr
C57BL/6J-Gatmem1Btlr/Gatmm1Btlr
decreased colon length J:252049
diarrhea J:252049
increased susceptibility to induced colitis J:252049
increased susceptibility to weight loss J:252049
Gatmm1Btlr/Gatm+
C57BL/6J-Gatmm1Btlr
increased sensitivity to xenobiotic induced morbidity/mortality J:252049
increased susceptibility to induced colitis J:252049
Gatmm1Btlr/Gatmm1Btlr
C57BL/6J-Gatmm1Btlr
abnormal duodenum crypts of Lieberkuhn morphology J:252049
decreased colon length J:252049
decreased creatine level J:252049
diarrhea J:252049
increased enterocyte apoptosis J:252049
increased sensitivity to xenobiotic induced morbidity/mortality J:252049
increased susceptibility to induced colitis J:252049
increased susceptibility to weight loss J:252049
Gatmtm1.1Isb/Gatmtm1.1Isb
B6.129-Gatmtm1.1Isb
abnormal eating behavior J:191142
abnormal gluconeogenesis J:191142
abnormal glucose homeostasis J:191142
abnormal spermatogenesis J:191142
abnormal testis morphology J:191142
abnormal urine amino acid level J:191142
decreased body length J:191142
decreased body mass index J:191142
decreased body weight J:191142
decreased circulating cholesterol level J:191142
decreased circulating glucose level J:191142
decreased circulating insulin level J:191142
decreased circulating leptin level J:191142
decreased circulating triglyceride level J:191142
decreased liver triglyceride level J:191142
decreased subcutaneous adipose tissue amount J:191142
decreased susceptibility to diet-induced obesity J:191142
decreased susceptibility to hepatic steatosis J:191142
decreased total body fat amount J:191142
decreased urine creatine level J:191142
decreased urine creatinine level J:191142
decreased white adipose tissue amount J:191142
female infertility J:191142
normal growth/size/body region phenotype J:191142
normal homeostasis/metabolism phenotype J:191142
hypoactivity J:191142
hypotonia J:191142
improved glucose tolerance J:191142
increased adipocyte glucose uptake J:191142
increased muscle cell glucose uptake J:191142
male infertility J:191142
scoliosis J:191142
Gatmtm1b(KOMP)Wtsi/Gatmtm1b(KOMP)Wtsi
C57BL/6N-Gatmtm1b(KOMP)Wtsi/Ieg
abnormal behavior J:211773
decreased circulating alkaline phosphatase level J:211773
decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating phosphate level J:211773
decreased circulating serum albumin level J:211773
decreased food intake J:211773
decreased grip strength J:211773
decreased leukocyte cell number J:211773
decreased prepulse inhibition J:211773
decreased red blood cell distribution width J:211773
decreased respiratory quotient J:211773
decreased startle reflex J:211773
female infertility J:211773
hypoactivity J:211773
male infertility J:211773
thrombocytopenia J:211773

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
06/04/2019
MGI 6.14
The Jackson Laboratory